Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 46Mesothelioma 40Carcinoma, Non-Small-Cell Lung 13Advanced Solid Tumors 6Unspecified Adult Solid Tumor, Protocol Specific 5Solitary Fibrous Tumor, Pleural 5Advanced Solid Tumor 4Lung Neoplasms 3Solid Tumors 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Lymphoma, Non-Hodgkin 2Breast Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Thymus Neoplasms 1Thymoma 1Solid Tumor Cancer 1Solid Tumor 1Severe combined immunodeficiency with sensitivity to ionizing radiation 1Sarcoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1

Interventions

TIC10 compound 1Sorafenib 1Radiosurgery 1Pemetrexed 1Imatinib Mesylate 1Cyclophosphamide 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unspecified Adult Solid Tumor × Pemetrexed × Other solid neoplasm × Clear all
NCT01450384 2016-02-23

Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors

Virginia Commonwealth University

Phase 1 Completed
37 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡